We ECHEMI Pharmaceutical Hereby Notified That Our New Product Line EXCIPIENT Has Landed!

Pharmaceutical excipients belong to the pharmaceutical manufacturing fine-molecule industry, so the growth of the excipient market is positively correlated with the growth of the pharmaceutical industry. According to the latest report released by market research firm Markets and Markets, the global pharmaceutical excipients market is expected to increase from US$7.9 billion in 2021 to US$10.6 billion in 2026, with a compound annual growth rate of 5.8% during the forecast period. Negligible impact of COVID-19 market growth is mainly driven by the continuous development of the pharmaceutical industry and the increasing R&D activities in this field. The generic drug market, the rapid growth of the biopharmaceutical industry, and the growing popularity of orphan drugs are also supporting the market.

In order to provide our customers with better services, ECHEMI Pharmaceutical has recently integrated our industry resources and reached a cooperation agreement with several Chinese manufacturers, aiming to sell more cost-effective excipients to the global market.

Our dominant varieties include binders, such as HPMC, PVP, etc., disintegrants, such as PVPP, etc., lubricants, magnesium stearate, etc., as well as thickeners, microcrystalline cellulose, etc. And all are from GMP factories based in China.